These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29616427)

  • 1. People in states worse than dead according to the EQ-5D UK value set: would they rather be dead?
    Bernfort L; Gerdle B; Husberg M; Levin LÅ
    Qual Life Res; 2018 Jul; 27(7):1827-1833. PubMed ID: 29616427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D weights.
    Norrlid H; Dahm P; Tennvall GR
    Scand J Pain; 2015 Jan; 6(1):24-30. PubMed ID: 29911578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between hypothetical and experience-based value sets for EQ-5D used in Sweden: Implications for decision makers.
    Aronsson M; Husberg M; Kalkan A; Eckard N; Alwin J
    Scand J Public Health; 2015 Dec; 43(8):848-54. PubMed ID: 26271493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
    Kiadaliri AA; Eliasson B; Gerdtham UG
    Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
    Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
    Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice Defines QALYs: A US Valuation of the EQ-5D-5L.
    Craig BM; Rand K
    Med Care; 2018 Jun; 56(6):529-536. PubMed ID: 29668646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
    Jia H; Zack MM; Moriarty DG; Fryback DG
    Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
    Zarate V; Kind P; Chuang LH
    Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unchained melody: revisiting the estimation of SF-6D values.
    Craig BM
    Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
    Lindkvist M; Feldman I
    Health Qual Life Outcomes; 2016 Sep; 14(1):134. PubMed ID: 27644119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.
    Harrison MJ; Davies LM; Bansback NJ; McCoy MJ; Farragher TM; Verstappen SM; Hassell A; Symmons DP
    Value Health; 2009 Sep; 12(6):1026-34. PubMed ID: 19473335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
    Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
    Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set.
    Kreimeier S; Greiner W
    Value Health; 2019 Jan; 22(1):31-37. PubMed ID: 30661631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.